DCA Partners and CVF Capital Acquire Cordant Health Solutions' Toxicology Direct Bill Division

April 10, 2023

DCA Partners, with co-investor CVF Capital Partners and financing support from Gladstone Capital, acquired the Toxicology Direct Bill division of Cordant Health Solutions in a carve-out from an unnamed financial institution. The division provides drug testing and medication monitoring services to parole/probation agencies, drug courts and treatment clinics across the United States and will continue operating under the Cordant name.

Targets
Toxicology Direct Bill division of Cordant Health Solutions
Sellers
Unnamed financial institution (owner since 2013)
Location
Arizona, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.